NMRA
Neumora Therapeutics, Inc.
0.4999$
-9.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.9% | -9.3% | -10.2% | -12.8% | -10.1% | -19.0% | -12.8% | -20.5% | +7.4% | -19.5% | -18.6% | |
| – | -9.0% | -7.4% | -10.0% | -12.5% | -9.9% | -18.8% | -12.5% | -20.6% | +7.6% | -19.5% | -18.6% | |
| – | -9.3% | -51.1% | -17.6% | +83.0% | -48.4% | -10.8% | -1.8% | +3.7% | +41.4% | -19.4% | -20.6% | |
| – | -10.9% | -6.9% | -12.1% | -8.2% | -9.9% | -18.9% | -12.7% | -21.2% | +6.4% | -19.4% | -20.6% | |
| – | +40.6% | -3.5% | +80.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -15.4% | -5.3% | -9.6% | +37.0% | -5.9% | -5.1% | +44.3% | +11.5% | +90.9% | -4.6% | -3.0% | |
| – | -13.8% | -2.0% | -6.0% | +37.3% | -5.9% | -5.0% | -25.5% | +22.1% | +25.6% | -7.2% | -7.8% | |
| – | -0.6% | +3.3% | +3.3% | -23.9% | -32.5% | -49.4% | -81.8% | +49.7% | +10.9% | +2.5% | +2.7% | |
| – | -84.9% | +342.7% | -27.5% | +464.4% | -45.8% | -68.2% | -38.8% | -14.8% | +515.5% | +49.7% | -18.0% | |
| – | – | – | – | – | – | – | – | +0.6% | +178.8% | -2.9% | -0.1% | |
| – | -8.5% | -9.5% | -10.2% | -15.9% | -10.5% | -20.4% | -19.9% | -27.7% | -21.4% | -32.0% | -37.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | -0.6% | +0.7% | +0.4% | +0.9% | +0.3% | +0.1% | +0.1% | +1.0% | +10.1% | +2.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.